{"id":"https://openalex.org/W2084148374","doi":"https://doi.org/10.1161/01.cir.0000160005.90598.41","title":"The Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): A Science Advisory From the American Heart Association","display_name":"The Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): A Science Advisory From the American Heart Association","alternate_titles":[],"publication_year":2005,"publication_date":"2005-03-21","ids":{"openalex":"https://openalex.org/W2084148374","doi":"https://doi.org/10.1161/01.cir.0000160005.90598.41","mag":"2084148374","pmid":"https://pubmed.ncbi.nlm.nih.gov/15781731"},"language":"en","primary_location":{"id":"doi:10.1161/01.cir.0000160005.90598.41","doi":"https://doi.org/10.1161/01.cir.0000160005.90598.41","is_oa":true,"landing_page_url":"https://doi.org/10.1161/01.cir.0000160005.90598.41","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.0000160005.90598.41","source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2084148374"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.0000160005.90598.41","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058801586","display_name":"JOEL S. BENNETT","orcid":"https://orcid.org/0000-0003-4650-221X","observed_orcids":["https://orcid.org/0000-0003-4650-221X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joel S. Bennett","raw_affiliation_strings":["Joel S. Bennett"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Joel S. Bennett","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079061954","display_name":"Alan Daugherty","orcid":"https://orcid.org/0000-0003-2093-3775","observed_orcids":["https://orcid.org/0000-0003-2093-3775"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alan Daugherty","raw_affiliation_strings":["Alan Daugherty"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alan Daugherty","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071844909","display_name":"David M. Herrington","orcid":"https://orcid.org/0000-0002-7670-6400","observed_orcids":["https://orcid.org/0000-0002-7670-6400"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David Herrington","raw_affiliation_strings":["David Herrington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"David Herrington","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005650203","display_name":"Philip Greenland","orcid":"https://orcid.org/0000-0002-6327-2439","observed_orcids":["https://orcid.org/0000-0002-6327-2439"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Philip Greenland","raw_affiliation_strings":["Philip Greenland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Philip Greenland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107844326","display_name":"Harold R. Roberts","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Harold Roberts","raw_affiliation_strings":["Harold Roberts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harold Roberts","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009159473","display_name":"Kathryn A. Taubert","orcid":"https://orcid.org/0000-0002-0110-4472","observed_orcids":["https://orcid.org/0000-0002-0110-4472"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kathryn A. Taubert","raw_affiliation_strings":["Kathryn A. Taubert"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kathryn A. Taubert","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.681,"has_fulltext":true,"cited_by_count":95,"citation_normalized_percentile":{"value":0.96731578,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"111","issue":"13","first_page":"1713","last_page":"1716"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10292","display_name":"Acute Myocardial Infarction Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.996999979019165},{"id":"https://openalex.org/keywords/nsaid-use","display_name":"NSAID use","score":0.753000020980835},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.6549999713897705},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.4569999873638153}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9746148586273193},{"id":"https://openalex.org/C2778484676","wikidata":"https://www.wikidata.org/wiki/Q20707196","display_name":"Nonsteroidal","level":2,"score":0.9002630710601807},{"id":"https://openalex.org/C2779703632","wikidata":"https://www.wikidata.org/wiki/Q581996","display_name":"Anti-inflammatory","level":2,"score":0.5075901746749878},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4437932074069977},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.440224826335907}],"mesh":[{"descriptor_ui":"D000572","descriptor_name":"American Heart Association","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002316","descriptor_name":"Cardiotonic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002316","descriptor_name":"Cardiotonic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011451","descriptor_name":"Prostaglandin-Endoperoxide Synthases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051546","descriptor_name":"Cyclooxygenase 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1161/01.cir.0000160005.90598.41","doi":"https://doi.org/10.1161/01.cir.0000160005.90598.41","is_oa":true,"landing_page_url":"https://doi.org/10.1161/01.cir.0000160005.90598.41","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.0000160005.90598.41","source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},{"id":"pmid:15781731","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15781731","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1161/01.cir.0000160005.90598.41","doi":"https://doi.org/10.1161/01.cir.0000160005.90598.41","is_oa":true,"landing_page_url":"https://doi.org/10.1161/01.cir.0000160005.90598.41","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.0000160005.90598.41","source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2084148374.pdf","grobid_xml":"https://content.openalex.org/works/W2084148374.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W1965992514","https://openalex.org/W1983707947","https://openalex.org/W2011327495","https://openalex.org/W2012801178","https://openalex.org/W2016071225","https://openalex.org/W2025653938","https://openalex.org/W2030768867","https://openalex.org/W2061857216","https://openalex.org/W2105605377","https://openalex.org/W2131343090","https://openalex.org/W2137005374","https://openalex.org/W2139776244","https://openalex.org/W2158131645","https://openalex.org/W2158968701","https://openalex.org/W2171061276","https://openalex.org/W2316102942","https://openalex.org/W2321390295"],"related_works":["https://openalex.org/W2139467829","https://openalex.org/W2131996761","https://openalex.org/W7099879599","https://openalex.org/W2133146428","https://openalex.org/W2112858809","https://openalex.org/W2093452916","https://openalex.org/W337651641","https://openalex.org/W2168451649","https://openalex.org/W7100289271","https://openalex.org/W2158271851"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2084148374","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
